Title
Category
Credits
Event date
Cost
  • 0.00 AMA PRA Category 1 Credit™
  • 0.00 ANCC
  • 0.00 Participation
  • 0.00 Participation/Attendance
$0.00
After viewing the video, please take the associated quiz.  You will need to score at least 80% on the quiz in order to proceed to the next module.Reminder: You have 3 weeks from your enrollment date to finish the course.
  • 0.00 AMA PRA Category 1 Credit™
  • 0.00 ANCC
  • 0.00 Participation
  • 0.00 Participation/Attendance
$0.00
This lesson contains the Healthy Bones for Life™ program a 1-hour presentation covering the basic aspects of osteoporosis and bone health.Healthy Bones for Life™ is the starting point for the education program. The video shown is a sample of a program that a Peer Educator would deliver.You will learn bone development over the ages, understand what osteoporosis is, bone loss and fractures. It's the perfect introduction to preventing bone loss, fracture prevention, bone-safe exercise and bone-healthy nutrition.
  • 0.00 AMA PRA Category 1 Credit™
  • 0.00 ANCC
  • 0.00 Participation
  • 0.00 Participation/Attendance
$0.00
The Calculator estimates fracture risk for women and men over age 45. It is available online at:https://americanbonehealth.org/calculator/What we’ll cover in this module
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
The presentation, "Vitamin D: What We Don’t Know," by Neil Binkley, MD, explores the ongoing controversies and knowledge gaps surrounding vitamin D. It examines current research, the complexities of measuring vitamin D levels, and the challenges of defining deficiency and sufficiency. The session discusses potential local effects of vitamin D, the role of inflammation in vitamin D status, and the limitations of existing clinical guidelines.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
The presentation "Osteoporosis in Men: 2024 Update" by Robert A. Adler, MD, addresses the often overlooked topic of osteoporosis in men. It highlights the unique aspects of bone aging and fracture risk in men, the higher mortality rates following fractures compared to women, and the critical need for effective screening and treatment strategies.
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 ANCC
  • 1.25 Participation
  • 1.25 Participation/Attendance
$45.00
The presentation, "Making the Case for a Secondary Fracture Prevention Program," focuses on the urgent need to improve outcomes in osteoporosis care through the establishment of Fracture Liaison Services (FLS). The session will cover the benefits of a coordinated, interdisciplinary model of care, strategies for successful program implementation, and the economic and clinical rationale for prioritizing secondary fracture prevention.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
The presentation, "Falls Risk Assessment and Common Exercise Questions," provides critical insights into assessing fall risk in individuals with osteoporosis and prescribing effective exercise interventions. Participants will learn about key risk factors, methods for conducting fall risk assessments, and strategies to implement exercises that improve balance and strength.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
The presentation, "Optimization Clinic for Total Joints," led by David Freeze, DNP, FNPBC, FLS, outlines the importance of integrating bone health assessments and osteoporosis management into the pathway for total joint arthroplasty patients. It addresses the risks associated with undiagnosed osteoporosis, the potential complications of joint surgery, and the benefits of a proactive approach.
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC
  • 0.75 Participation
  • 0.75 Participation/Attendance
$45.00
The presentation, "State of the Art: Hormone Therapy 2024," by JoAnn V. Pinkerton, MD, FACOG, MSCP, covers the latest evidence and guidance on hormone therapy (HT) for menopausal symptoms and bone health. It discusses the history and evolution of hormone therapy, benefits and risks, the timing hypothesis for cardiovascular outcomes, and special considerations for different populations.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
  • 1.00 Participation/Attendance
$45.00
The presentation, "Discontinuing Treatment – End of Life," by Cathleen Colón Emeric, MD, MHS, addresses the complexities involved in managing osteoporosis treatment in individuals nearing the end of life. It covers the relationship between functional status and fracture risk, strategies for estimating life expectancy, and the risks and benefits of continuing osteoporosis medications.

Pages